![Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint? | tctmd.com Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint? | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2016-05/4441680.png?itok=lMMgDNkV)
Should Clinical Trial Interpretation Be Dominated by A P Value of 0.05 for the Primary Endpoint? | tctmd.com
![When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More | tctmd.com When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2015-10/131042.png?itok=29_t7LUb)
When Is the Primary Endpoint Not Enough? Pitfalls in Primary Endpoint Selection and Assumptions, Power, and More | tctmd.com
![endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services](https://mma.prnewswire.com/media/1434995/endpoint_Clinical_personnel.jpg?w=500)
endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services
![endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services](https://mma.prnewswire.com/media/1434995/endpoint_Clinical_personnel.jpg?p=facebook)
endpoint Clinical Announces the Appointment of Christine Hurley as its Senior Vice President, Client Services
![Financial Toxicity as an Endpoint in Prospective Clinical Trials Involving Radiation Therapy - Advances in Radiation Oncology Financial Toxicity as an Endpoint in Prospective Clinical Trials Involving Radiation Therapy - Advances in Radiation Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/aff7e98e-180d-4974-9a38-bf01f74ebf20/gr1.jpg)
Financial Toxicity as an Endpoint in Prospective Clinical Trials Involving Radiation Therapy - Advances in Radiation Oncology
![endpoint Clinical on Twitter: "Interested in joining our growing team? Join us at our Recruitment Drive or Apply today to learn more about your opportunities to be part of the leading IRT endpoint Clinical on Twitter: "Interested in joining our growing team? Join us at our Recruitment Drive or Apply today to learn more about your opportunities to be part of the leading IRT](https://pbs.twimg.com/media/ESufuv8X0AAYHI5.jpg:large)